AcQMap High Resolution Imaging and Mapping System— 510(k) K222209

Name: FDA 510(k) clearance K222209
Creator: U.S. Food and Drug Administration
Published: 2022-10-17

Substantially Equivalent

Acutus Medical, Inc.

FDA 510(k) clearance K222209 for AcQMap High Resolution Imaging and Mapping System, Substantially Equivalent on 2022-10-17. Applicant: Acutus Medical, Inc.. Device class: 2.

Clearance details

Applicant: Acutus Medical, Inc.
Product code: Code DQK
Device class: Class 2
Regulation: 21 CFR 870.1425
Advisory panel: Cardiovascular
Date received: 2022-07-25
Decision date: 2022-10-17
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Carlsbad, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code DQK

view all

K253692 — AVVIGO+ Multi-Modality Guidance System2026-08-21
K262005 — Affera Integrated Mapping System2026-08-21
K253576 — CorVista System® with PCWP Add-On2026-07-26
K262006 — EnSite X EP System2026-07-15
K252978 — ScioCardio ECG Analysis Platform2026-07-09

More clearances from Acutus Medical, Inc.

view all

K233691 — FlexCath Cross Transseptal Solution2023-12-17
K231091 — AcQMap High Resolution Imaging and Mapping System2023-07-10
K230606 — AcQMap® High Resolution Imaging and Mapping System2023-05-02
K220784 — AcQMap High Resolution Imaging and Mapping System2022-07-01
K210766 — AcQMap 3D Imaging and Mapping Catheter, Model 9000092022-06-21

Adverse events under product code DQK

product code DQK

Death: 10
Injury: 225
Malfunction: 2,123
Other: 2
Total: 2,360

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.